VolitionRX Ltd Stock OTC Bulletin Board
Stocks
VNRX
US9286611077
Biotechnology & Medical Research
| Market Cap | 5.69M 4.87M 4.56M 4.17M 7.84M 544M 7.94M 53.89M 21.01M 274M 21.37M 20.9M 905M | P/E 2026 * |
-0.2x | P/E 2027 * | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 5.69M 4.87M 4.56M 4.17M 7.84M 544M 7.94M 53.89M 21.01M 274M 21.37M 20.9M 905M | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 1.08x |
| Free-Float |
92.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: VolitionRX Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 55 | 06/10/2011 |
Terig Hughes
DFI | Director of Finance/CFO | 56 | 01/02/2021 |
Andrew Retter
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Cameron Reynolds
BRD | Director/Board Member | 55 | 06/10/2011 |
Alan Colman
BRD | Director/Board Member | 77 | 06/10/2011 |
Phillip Barnes
BRD | Director/Board Member | 64 | 09/10/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 5.69M | |
| +2.16% | +5.05% | +105.78% | +303.57% | 4.15B | |
| -7.79% | +18.77% | +226.38% | +31.80% | 3.76B | |
| +1.24% | +2.57% | +43.76% | +63.68% | 3.4B | |
| +3.45% | +7.26% | +288.57% | +463.92% | 2.51B | |
| -3.61% | +3.84% | -18.47% | -20.90% | 2.41B | |
| -0.88% | +16.87% | +27.81% | - | 1.48B | |
| +4.22% | +51.58% | +261.51% | -17.56% | 1.29B | |
| -2.40% | -5.13% | +17.99% | +39.91% | 1B | |
| -2.72% | -2.82% | -36.21% | -1.66% | 552M | |
| Average | -0.63% | +11.21% | +101.90% | +107.84% | 2.28B | |
| Weighted average by Cap. | -0.77% | +10.62% | +121.38% | +143.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.49M 2.13M 2M 1.83M 3.43M 238M 3.47M 23.58M 9.2M 120M 9.35M 9.15M 396M | 5.27M 4.51M 4.22M 3.86M 7.25M 504M 7.35M 49.87M 19.45M 253M 19.78M 19.35M 837M |
| Net income | -21.62M -18.52M -17.33M -15.86M -29.77M -2.07B -30.17M -205M -79.85M -1.04B -81.19M -79.43M -3.44B | -18.42M -15.78M -14.76M -13.51M -25.36M -1.76B -25.7M -174M -68.02M -885M -69.16M -67.66M -2.93B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
